![Liora Sklair-Tavron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liora Sklair-Tavron
Chief Operating Officer at Regentis Biomaterials Ltd.
Liora Sklair-Tavron active positions
Companies | Position | Start | End |
---|---|---|---|
Regentis Biomaterials Ltd.
![]() Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Chief Operating Officer | 2018-02-28 | - |
Career history of Liora Sklair-Tavron
Former positions of Liora Sklair-Tavron
Companies | Position | Start | End |
---|---|---|---|
Bioblast Pharma Ltd.
![]() Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | General Counsel | 2015-02-28 | - |
Training of Liora Sklair-Tavron
Weizmann Institute of Science | Doctorate Degree |
Statistics
International
Israel | 4 |
Operational
General Counsel | 1 |
Doctorate Degree | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Bioblast Pharma Ltd.
![]() Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
Regentis Biomaterials Ltd.
![]() Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Health Technology |
- Stock Market
- Insiders
- Liora Sklair-Tavron
- Experience